Back to Search
ROSELIND NAM, DMD
DMD
Orthodontics and Dentofacial Orthopedics Dentistry
NPI: 1982863437Individual
Specialties, Licenses & Credentials
Orthodontics and Dentofacial Orthopedics DentistryPrimary
Dentist — Orthodontics and Dentofacial Orthopedics
Code: 1223X0400X
61090(CA)8012(NE)DE60139654(WA)
Research & Publications (20)
Utility of incorporating genetic variants for the early detection of prostate cancer.
PMID 19223501·Clin Cancer Res·2009
8-other
Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era.
PMID 19282170·Surg Oncol·2009
6-review
A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model.
PMID 19401531·Cancer Prev Res (Phila)·2009
7-preclinical
ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
PMID 19409690·Eur Urol·2009
6-review
Lymph node assessment and lymphadenectomy in prostate cancer.
PMID 19170044·J Surg Oncol·2009
6-review
A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
PMID 17876339·Prostate Cancer Prostatic Dis·2008
4-observational
Rapid progression of prostate cancer in men with a BRCA2 mutation.
PMID 18577985·Br J Cancer·2008
8-other
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.
PMID 17404365·J Clin Oncol·2007
1-meta
Serial personal digital assistant data capture of health-related quality of life: a randomized controlled trial in a prostate cancer clinic.
PMID 17617906·Health Qual Life Outcomes·2007
4-observational
Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.
PMID 18042933·J Natl Cancer Inst·2007
7-preclinical
Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.
PMID 17172822·Cancer Biol Ther·2007
8-other
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer.
PMID 17971772·Br J Cancer·2007
8-other
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
PMID 16515983·J Urol·2006
8-other
Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis.
PMID 16526983·Can J Urol·2006
6-review
Prostate sparing radical cystectomy--not for all, but an option for some.
PMID 16526989·Can J Urol·2006
6-review
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
PMID 16672122·Can J Urol·2006
8-other
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
PMID 17085659·Clin Cancer Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 23535 NE NOVELTY HILL RD # D308
REDMOND, WA 98053 - Phone
- (425) 868-7770
Quick Facts
- NPI
- 1982863437
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile